PDCD1 and cancer: Among the many different immune checkpoints that regulate T-cell activation, cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) and programmed cell death protein 1 (PD1) are the most well characterized and studied for cancer immunotherapy.